| # | Drug | Count |
|---|---|---|
| 0 | LAMIVUDINE | 3 |
| 1 | LAMIVUDINE ORAL | 3 |
| 2 | RALTEGRAVIR | 3 |
| 3 | FLUCONAZOLE | 2 |
| 4 | LOPINAVIR AND RITONAVIR | 2 |
| 5 | ALENDRONATE SODIUM | 1 |
| 6 | CYCLOSPORINE | 1 |
| 7 | LEVONORGESTREL | 1 |
| 8 | OXALIPLATIN | 1 |
| 9 | PREDNISONE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RALTEGRAVIR | 3 | 0.0006 |
| 1 | LOPINAVIR AND RITONAVIR | 2 | 0.0001 |
| 2 | LAMIVUDINE | 3 | 0.0001 |
| 3 | FLUCONAZOLE | 2 | 0.0000 |
| 4 | OXALIPLATIN | 1 | 0.0000 |
| 5 | ALENDRONATE SODIUM | 1 | 0.0000 |
| 6 | CYCLOSPORINE | 1 | 0.0000 |
| 7 | LEVONORGESTREL | 1 | 0.0000 |
| 8 | PREDNISONE | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0001 |
| 1 | Protease Inhibitor [EPC] | 2 | 0.0000 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 2 | 0.0000 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 3 | 0.0000 |
| 4 | Azole Antifungal [EPC] | 2 | 0.0000 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 7 | Progestin [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 1 | 0.0000 |